Literature DB >> 10509994

Bidirectional Glenn shunt in association with congenital heart repairs: the 1(1/2) ventricular repair.

C Mavroudis1, C L Backer, L M Kohr, B J Deal, J Stinios, A J Muster, D F Wax.   

Abstract

BACKGROUND: The bidirectional Glenn shunt has been used to incorporate a smaller tripartite ventricle into the circulation and create pulsatile pulmonary artery flow. We reviewed our operative experience and assessed hemodynamics of the bidirectional Glenn shunt in 1(1/2) ventricular repair or in conjunction with other repairs of congenital heart defects.
METHODS: Between 1992 and 1998, 15 patients (mean age, 8.1+/-7.9 years) had bidirectional Glenn shunt in association with repair of congenital heart defects. Eighty-seven percent had at least one previous operation. All patients had simultaneous or previous intracardiac repair and had bidirectional Glenn shunt to volume unload the small right ventricle (group A, n = 7), to unload the poorly functioning right ventricle (group B, n = 2), to redirect superior vena cava-pulmonary venous atrial connection to treat cyanosis (group C, n = 2), or to unload the pulmonary left ventricle for residual intracavitary hypertension in patients with L-transposition of the great arteries, ventricular septal defect, and pulmonary stenosis (group D, n = 4). Intraoperative hemodynamic assessment was done in 2 patients in group A by selective use of inflow occlusion and flow probes.
RESULTS: All patients survived. Four patients had successful, concurrent arrhythmia circuit cryoablation for Wolf-Parkinson-White syndrome (n = 1) or atrial reentry tachycardia (n = 3). Superior and inferior vena caval flow averaged 36% and 64% of cardiac output, respectively. Postoperative superior vena caval pressure (n = 13) was 13.7+/-4.0 mm Hg with pulmonary arterial flow pattern contributed by the ventricle in systole (pulsatile) and the superior vena cava in diastole (laminar).
CONCLUSIONS: The bidirectional Glenn shunt is an effective adjunct to congenital heart repair to treat pulmonary ventricular pressure-volume problems and anomalous superior vena caval to left atrial connections.

Entities:  

Mesh:

Year:  1999        PMID: 10509994     DOI: 10.1016/s0003-4975(99)00562-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Biventricular repair versus uni-ventricular repair for pulmonary atresia with intact ventrical septum: A systematic review.

Authors:  Fei-Fei Li; Xin-Ling Du; Shu Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

2.  Bidirectional Glenn shunt as an adjunct to surgical repair of congenital heart disease associated with pulmonary outflow obstruction: relevance of the fluid pressure drop-flow relationship.

Authors:  Robert Ascuitto; Nancy Ross-Ascuitto; Joshua Wiesman; Serafin Deleon
Journal:  Pediatr Cardiol       Date:  2008-06-13       Impact factor: 1.655

Review 3.  Surgical strategy for pulmonary atresia with intact ventricular septum: initial management and definitive surgery.

Authors:  Naoki Yoshimura; Masahiro Yamaguchi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-07-14

4.  Congenitally Corrected Transposition of the Great Arteries: Current Treatment Options.

Authors:  Karrie Dyer; Thomas P. Graham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-10

5.  Intrapulmonary shear stress enhancement: a new therapeutic approach in pulmonary arterial hypertension.

Authors:  Sayed Nour; Gang Dai; Daniel Carbognani; Minze Feng; Daya Yang; Nermine Lila; Juan Carlos Chachques; Guifu Wu
Journal:  Pediatr Cardiol       Date:  2012-05-06       Impact factor: 1.655

6.  The role of the Fontan operation in the treatment of congenitally corrected transposition of the great arteries.

Authors:  Tom R Karl
Journal:  Ann Pediatr Cardiol       Date:  2011-07

7.  Congenitally Corrected Transposition of the Great Arteries: Mid-term Outcomes of Different Surgical Strategies.

Authors:  Xiaomin He; Bozhong Shi; Zhiying Song; Yanjun Pan; Kai Luo; Qi Sun; Zhongqun Zhu; Zhiwei Xu; Jinghao Zheng; Zhifang Zhang
Journal:  Front Pediatr       Date:  2022-02-03       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.